Health-related quality of life in diabetic people with different vascular risk

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Oliva, Juan ^a   Fernández Bolaños, Antonio ^a   Hidalgo, Álvaro ^a  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DIABETES MELLITUS; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; QUALITY OF LIFE; RISK FACTOR; SPAIN; VASCULAR DISEASE;

ADULT; AGED; DIABETES MELLITUS; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RISK FACTORS; SPAIN; VASCULAR DISEASES;

EID: 84866482749     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-812     Document Type: Article

References (51)

1. Diagnosis and classification of diabetes mellitus. American Diabetes Association, Diabetes Care 2009 32 Suppl 62 S67 19118289
2. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Wild S, Roglic G, Green A, Sicree R, King H, Diabetes Care 2004 27 1047 1053 10.2337/diacare.27.5.1047 15111519
3. WHO, Diabetes action now: an initiative of the World Health Organization and the International Diabetes Federation. Ginebra, 2004
4. Economic Costs of Diabetes in the U.S. in 2007. American Diabetes Association, Diabetes Care 2008 31 596 615 18308683
5. Revealing the cost of Type II diabetes in Europe. Jonsson B, Diabetologia 2002 45 5 S12 10.1007/s00125-002-0858-x 12136405
6. The cost burden of diabetes mellitus: the evidence from Germany-the CoDiM study. Koster I, Von Ferber L, Ihle P, Schubert I, Hauner H, Diabetologia 2006 49 498 504
7. Direct Health Care Costs of Diabetic Patients in Spain. Oliva J, Lobo F, Molina B, Monereo S, Diabetes Care 2004 27 2616 2621 10.2337/diacare.27.11.2616 15504995
8. Direct and indirect costs of cardiovascular and cerebrovascular complications of type II diabetes. Macleod KM, Tooke JE, Pharmacoeconomics 1995 8 Suppl 1 46 51 10155601
9. Diabetes mellitus and the St Vincent Declaration, The economic implications. Leese B, Pharmacoeconomics 1995 7 292 307 10.2165/00019053- 199507040-00004 10155319
10. Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered. Norlund A, Apelqvist J, Bitzen PO, Nyberg P, Schersten B, J Intern Med 2001 250 57 65 10.1046/j.1365-2796.2001.00852.x 11454143
11. Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Solli O, Stavem K, Kristiansen IS, Health Qual Life Outcomes 2010 8 18 10.1186/1477-7525-8-18 20132542
12. Valuing health-related quality of life in diabetes. Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP, Engelgau MM, Kaplan RM, Herman WH, Diabetes Care 2002 25 2238 2243 10.2337/diacare.25.12.2238 12453967
13. Clustering of multiple healthy lifestyle habits and health-related quality of life among U.S. adults with diabetes. Li C, Ford ES, Mokdad AH, Jiles R, Giles WH, Diabetes Care 2007 30 1770 1776 10.2337/dc06-2571 17456843
14. Health-related quality of life and physical activity in persons at high risk for type 2 diabetes. Häkkinen A, Kukka A, Onatsu T, Järvenpää S, Heinonen A, Kyröläinen H, Tomas-Carus P, Kallinen M, Disabil Rehabil 2009 31 799 805 10.1080/08916930802354930 19034723
15. Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes. Williamson DA, Rejeski J, Lang W, Van Dorsten B, Fabricatore AN, Toledo K, Arch Intern Med 2009 169 163 171 10.1001/archinternmed.2008.544 19171813
16. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Clarke P, Gray A, Holman R, Med Decis Making 2002 22 340 349 12150599
17. Patient perceptions of quality of life with diabetes-related complications and treatments. Huang ES, Brown SES, Ewigman BG, Foley EC, Meltzer DO, Diabetes Care 2007 30 2478 2483 10.2337/dc07-0499 17623824
18. Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin. Lloyd A, Sawyer W, Hopkinson P, Value Health 2001 4 392 400 10.1046/j.1524-4733.2001.45029.x 11705130
19. Quality of life and depression of people living with type 2 diabetes mellitus and those at low and high risk for type 2 diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors leading to Diabetes (SHIELD). Grandy S, Chapman RH, Fox KM, Int J Clin Pract 2008 62 562 568 10.1111/j.1742-1241.2008.01703.x 18266708
20. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Redekop WK, Koopmanschap MA, Stolk RP, Rutten GEHM, Wolffenbuttel BHR, Niessen LW, Diabetes Care 2002 25 458 463 10.2337/diacare.25.3.458 11874930
21. Impact of diabetes on health-related quality of life in a population study in Japan. Saito I, Inami F, Ikebe T, Moriwaki C, Tsubakimoto A, Yonemasu K, Ozawa H, Diabetes Res Clin Pract 2006 73 51 57 10.1016/j.diabres.2005.11.015 16417943
22. The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus. Janssen MF, Lubetkin EI, Sekhobo JP, Pickard AS, Diabet Med 2011 28 395 413 10.1111/j.1464-5491.2010.03136.x 21392061
23. Características metodológicas de la Encuesta de Salud de Cataluña 2006. Mompart-Penina A, Medina-Bustosa A, Guillén-Estany M, Alcañiz-Zanón M, Brugulat-Guiterasa P, Med Clin (Barc) 2011 137 (Supl 2) 3 8
24. EuroQol- A new facility for the measurement of healthy-related quality of life. The Euroqol Group, Health Policy 1990 16 199 208 10109801
25. EQ-5D: a measure of health status from the EuroQol Group. Rabin R, De Charro F, Ann Med 2001 33 337 343 10.3109/07853890109002087 11491192
26. Guidelines for computer modeling of diabetes and its complications (Consensus Statement). American Diabetes Association Consensus Panel, Diabetes Care 2004 27 2262 2265 15333499
27. Cardiovascular disease risk profiles. Anderson KM, Odell PM, Wilson PWF, Kannel WB, Am Heart J 1991 121 293 298 10.1016/0002-8703(91)90861-B 1985385
28. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Gu K, Cowie C, Harris M, Diabetes Care 1998 21 1138 1145 10.2337/diacare.21.7.1138 9653609
29. Estimating the benefits of modifying risk factors of cardiovascular disease: a comparison of primary vs secondary prevention. Grover SA, Paquet S, Levinton C, Coupal L, Zowall H, Arch Intern Med 1998 158 655 662 10.1001/archinte.158.6.655 9521231
30. Using the Framingham model to predict heart disease in the United Kingdom: retrospective study. Ramachandran S, French JM, Vanderpump MPJ, Croft P, Neary RH, BMJ 2000 320 676 677 10.1136/bmj.320.7236.676 10710574
31. Validation of the Framingham coronary heart disease prediction scores. D'Agostino RB, Grundy SM, Sullivan LM, Wilson P, JAMA 2001 286 180 187 10.1001/jama.286.2.180 11448281
32. Predicting CHD risk in patients with diabetes mellitus. Yeo WW, Rowland Yeo K, Diabet Med 2001 18 341 344 10.1046/j.1464-5491.2001.00510.x 11472442
33. The UKPDS Risk Engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Stevens RJ, Kothari V, Adler AI, Stratton IM, United Kingdom Prospective Diabetes Study (UKPDS) Group, Clin Sci 2001 101 671 679 10.1042/CS20000335 11724655
34. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, Eur Heart J 2003 24 987 1003 10.1016/S0195-668X(03)00114-3 12788299
35. Diabetes mellitus and hypertension have comparable adverse effects on health-related quality of life. Poljicanin T, Adjukovic D, Sekerija M, Pibernik-Okanovic M, Metelko Z, Vuletic G, BMC Public Health 2010 10 12 10.1186/1471-2458-10-12 20070882
36. Prevalence and risk factors of diabetes and impaires fasting glucose in Nauru. Khambalia A, Phongsavan P, Smith BJ, Kefe K, Fitzhardinge A, Bauman AE, BMC Public Health 2011 11 719 10.1186/1471-2458-11-719 21943388
37. Greene WH, Econometric Analysis New York, MacMillan 2000
38. Spanish Ministry Of Health And Social Policy, Estrategia en Diabetes del Sistema Nacional de Salud MSPS, Madrid 2007
39. Marginal differences in health-related quality of life of diabetic patients with and without macrovascular comorbid conditions in the United States. Fu AZ, Qiu Y, Radican L, Luo N, Qual Life Res 2011 20 825 832 10.1007/s11136-010-9819-x 21165701
40. Characterization and comparison of health-related utility in people with diabetes with various single and multiple vascular complications. Morgan CL, McEwan P, Morrissey M, Peters JR, Poole C, Currie CJ, Diabet Med 2006 23 10 1100 1105 10.1111/j.1464-5491.2006.01936.x 16978374
41. Comparison of the minimally important difference for two health state utility measures: EQ-5 D and SF-6D. Walters SJ, Brazier JE, Qual Life Res 2005 14 1523 1532 10.1007/s11136-004-7713-0 16110932
42. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Pickard AS, Neary MP, Cella D, Health Qual Life Outcomes 2007 5 70 10.1186/1477-7525-5-70 18154669
43. Predictors of health-related quality of life in type II diabetic patients in Greece. Papadopoulos AA, Kontodimopoulos N, Frydas A, Ikonomakis E, Niakas D, BMC Public Health 2007 7 186 10.1186/1471-2458-7-186 17663782
44. Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4). Kleefstra N, Landman GWD, Houweling ST, Ubink-Veltmaat LJ, Logtenberg SJJ, Meyboom-De Jong B, Coyne JC, Groenier KH, Bilo HJG, Diabetes Care 2008 31 932 933 10.2337/dc07-2072 18319325
45. Low health-related quality of life is associated with all-cause mortality in patients with diabetes on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study. Hayashino Y, Fukuhara S, Akiba T, Akizawa T, Asano Y, Saito S, Kurokawa K, Diabet Med 2009 26 921 927 10.1111/j.1464-5491.2009.02800.x 19719714
46. Health-related quality of life and health-adjusted life expectancy of people with diabetes in Ontario, Canada, 1996-1997. Manuel DG, Schultz SE, Diabetes Care 2004 27 407 414 10.2337/diacare.27.2.407 14747221
47. A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Gorber SC, Tremblay M, Moher D, Gorber B, Obes Rev 2007 8 4 307 326 10.1111/j.1467-789X.2007.00347.x 17578381
48. Validity of self-report screening for overweight and obesity, Evidence from the Canadian Community Health Survey. Elgar FJ, Stewart JM, Can J Public Health 2008 99 5 423 427 19009930
49. The determinants of misreporting weight and height: The role of social norms. Gil J, Mora T, Econ Hum Biol 2011 9 1 78 91 10.1016/j.ehb.2010.05.016 20621569
50. Prevalence of known diabetes mellitus and unknown diabetes in adults from Castilla-La Mancha, Spain. Giralt Muiña P, Gutiérrez Avila G, Ballester Herrera MJ, Botella Romero F, Angulo Donado JJ, Med Clin (Barc). 2011 137 484 490 10.1016/j.medcli.2010.11.019
51. Health related quality of life and comorbidity. A descriptive analysis comparing EQ-5D dimensions of patients in the German disease management program for type 2 diabetes and patients in routine care. Ose D, Miksch A, Urban E, Natanzon I, Szecsenyi J, Kunz CU, Freund T, BMC Health Serv Res 2011 11 179 10.1186/1472-6963-11-179 21810241